Physician profile
Joseph F Quinn
NPI 1831107390
$12,552.78
in general payments reported to CMS, 2019-2025
10 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $1,181 · 2022: $4,811 · 2023: $3,234 · 2024: $2,625 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,100 · Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,100.00 |
| Food and Beverage | $160.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $8,400.00 | 2022-2025 | |
| Travere Therapeutics, INC. | $2,700.00 | 2019-2023 | Chenodal |
| Biogen, INC. | $1,181.00 | 2020 | |
| Genentech USA, INC. | $111.04 | 2022 | |
| Ge Healthcare | $108.82 | 2023 | |
| Abbvie INC. | $51.92 | 2025 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.